Circulating Epithelial Tumor Cell (CETC) Monitoring during SERM and Aromatase Inhibitor Treatment for Early Detection of Patients Resistant to Tamoxifen.

被引：0
|
作者：
Pachmann, K.
Camara, O.
Rabenstein, C.
Winzer, H.
Runnebaum, I. B.
机构：
[1] Univ Jena, Univ Hosp, Jena, Germany
[2] Transfus Ctr, Bayreuth, Germany
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：808S / 809S
页数：2
相关论文
共 50 条
  • [1] Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy
    Pachmann, Katharina
    Camara, Oumar
    Kohlhase, Annika
    Rabenstein, Carola
    Kroll, Torsten
    Runnebaum, Ingo B.
    Hoeffken, Klaus
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (05) : 821 - 828
  • [2] Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy
    Katharina Pachmann
    Oumar Camara
    Annika Kohlhase
    Carola Rabenstein
    Torsten Kroll
    Ingo B. Runnebaum
    Klaus Hoeffken
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 821 - 828
  • [3] Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radiotherapy of Breast Cancer Patients
    Maeurer, Matthias
    Pachmann, Katharina
    Wendt, Thomas
    Schott, Dorothea
    Wittig, Andrea
    CURRENT ONCOLOGY, 2021, 28 (05) : 3507 - 3524
  • [4] Circulating epithelial tumor cells (CETC) during preoperative chemotherapy (CTX) of patients with gastric cancer.
    Schmalenberg, Harald
    Pachmann, Katharina
    Pauligk, Claudia
    Hochhaus, Andreas
    Al-Batran, Salah-Eddin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer
    Camara, O.
    Rengsberger, M.
    Egbe, A.
    Koch, A.
    Gajda, M.
    Hammer, U.
    Jorke, C.
    Rabenstein, C.
    Untch, M.
    Pachmann, K.
    ANNALS OF ONCOLOGY, 2007, 18 (09) : 1484 - 1492
  • [6] Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment
    Camara, Oumar
    Joerke, Cornelia
    Hammer, Ulrike
    Egbe, Anne
    Rabenstein, Carola
    Runnebaum, Ingo B.
    Hoeffken, Klaus
    Pachmann, Katharina
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (04) : 643 - 647
  • [7] The initial response of circulating epithelial tumor cells (CETC) during primary systemic therapy of breast cancer is predictive for early relapse
    Pachmann, K.
    Camara, O.
    Gajda, M.
    Untch, M.
    Hoeffken, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 136 - 136
  • [8] Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment
    Oumar Camara
    Cornelia Jörke
    Ulrike Hammer
    Anne Egbe
    Carola Rabenstein
    Ingo B. Runnebaum
    Klaus Hoeffken
    Katharina Pachmann
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 643 - 647
  • [9] Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer
    Hou, June Y.
    Chapman, Jocelyn S.
    Kalashnikova, Ekaterina
    Pierson, William
    Smith-McCune, Karen
    Pineda, Geovanni
    Vattakalam, Reena Marie
    Ross, Alexandra
    Mills, Meredith
    Suarez, Carlos J.
    Davis, Tracy
    Edwards, Robert
    Boisen, Michelle
    Sawyer, Sarah
    Wu, Hsin-Ta
    Dashner, Scott
    Aushev, Vasily N.
    George, Giby, V
    Malhotra, Meenakshi
    Zimmermann, Bernhard
    Sethi, Himanshu
    ElNaggar, Adam C.
    Aleshin, Alexey
    Ford, James M.
    GYNECOLOGIC ONCOLOGY, 2022, 167 (02) : 334 - 341
  • [10] An increase in cell number at completion of therapy may develop as an indicator of early relapse: Quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer
    Pachmann K.
    Dengler R.
    Lobodasch K.
    Fröhlich F.
    Kroll T.
    Rengsberger M.
    Schubert R.
    Pachmann U.
    Journal of Cancer Research and Clinical Oncology, 2008, 134 (1) : 59 - 65
12345